SCHEMBL4724317

SCHEMBL4724317

CC(C(N)=O)N1CCN(c2ncccn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 2/20 0.47
OGA O60502 6/20 0.46
CYP2C19 P33261 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PKM P14618 1/20 0.43
LIPE Q05469 1/20 0.43
SLC6A7 Q99884 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29246743 0.85 KDM4E (0.51) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL3476407 0.84 KDM4E (0.48) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL4766661 0.82 SMN1; SMN2 (0.61) KDM4EALDH1A1SMN1; SMN2TDP1LMNA
SCHEMBL4723632 0.82 SMN1; SMN2 (0.61) KDM4EALDH1A1SMN1; SMN2TDP1LMNA
SCHEMBL7546262 0.78 OGA (0.51) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL10530529 0.78 LMNA (0.53) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL5962506 0.77 OGA (0.54) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL16026595 0.76 MEN1 (0.37) RAB9AKDM4EALDH1A1LMNAMEN1
SCHEMBL4724307 0.76 HRH3 (0.52) NPC1RAB9AALDH1A1OGAMEN1
SCHEMBL4723624 0.76 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917262-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X3 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2008-05-07 EP disclosed
WO-2007020194-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-02-22 WO disclosed